Kiadis Pharma NV products

We are leveraging our IntelliSelect® platforms to develop bispecific antibodies, which can simultaneously bind to two cells or molecules. Targets may be located on two different cells or maybe two different molecules and a bispecific antibody brings those cells or molecules together. Bispecific antibodies can also bind two different targets on the same cell or bind two different soluble proteins, providing enhanced specificity or novel biological activity.